Treatment for glioblastoma (GBM)
This site is intended for US healthcare professionals only.

Welcome to the Optune® Exchange Peer-to-Peer Program!

Whether you already manage patients on Optune or are considering incorporating Optune into your everyday practice, take the opportunity to speak with one of your Optune experienced peers.

The Optune Exchange Peer-to-Peer Program provides 30 minute educational programs for healthcare professionals looking to learn more about Optune regarding any of the following topics:

  • "Optune Clinical Experience: Unprecedented 5-year Survival Results in Newly Diagnosed GBM"

    • Reviews the trial design for EF-14 and summarizes the results of the 5-year analysis

  • "Discussing Optune with Patients and Caregivers: Tips and Resources for Your Practice"

    • Provides helpful tips and resources available for discussing Optune with your patients and their caregivers

  • "Supporting Patients on Optune: Lifestyle Integration and Proper Scalp Care"

    • Highlights the importance of maximizing time on therapy and reviews tips for prevention and management of possible skin irritation

To sign up for any of these programs, please complete and submit the information below. Novocure will confirm your request within 24 hours.

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).